1418759-38-2

Basic information

• Product Name: 4-(3-chloro-4-methoxybenzyloxy)-2-(methylsulfinyl)-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide
• Synonyms: 4-(3-chloro-4-methoxybenzyloxy)-2-(methylsulfinyl)-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide
• CAS NO: 1418759-38-2
• Molecular Weight: 447.902
• Mol File: 1418759-38-2.mol

Chemical Properties

• CAS DataBase Reference: 4-(3-chloro-4-methoxybenzyloxy)-2-(methylsulfinyl)-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(3-chloro-4-methoxybenzyloxy)-2-(methylsulfinyl)-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide(1418759-38-2)
• EPA Substance Registry System: 4-(3-chloro-4-methoxybenzyloxy)-2-(methylsulfinyl)-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide(1418759-38-2)

Safety Data

• Hazardous Substances Data: 1418759-38-2(Hazardous Substances Data)

Upstream product

• 5909-24-0 4-chloro-2-methanesulfanylpyrimidine-5-carboxylic acid ethyl ester 
• 14503-45-8 3-chloro-4-methoxybenzyl alcohol 
• 1418759-37-1 4-(3-chloro-4-methoxybenzyloxy)-2-(methylmercapto)-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide 
• 1418759-34-8 4-(3-chloro-4-methoxybenzyloxy)-2-(methylmercapto)pyrimidine-5-carboxylic acid 
• 1418759-33-7 ethyl 4-(3-chloro-4-methoxybenzyloxy)-2-(methylmercapto)pyrimidine-5-carboxylate 

Downstream Products

• 1418759-13-3 2-(3-azadicyclo[3.1.0]hexan-3-yl)-4-(3-chloro-4-methoxybenzyloxy)-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide 

Relevant articles and documents

HETEROCYCLIC SUBSTITUTED PYRIMIDINE COMPOUND

The present invention pertains to the field of medical technology, and particularly relates to a heterocyclic substituted pyrimidine compound represented by General Formula (I) and its pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4 and R5 are as defined in the description, the present invention also relates to a preparation method of the compound, a pharmaceutical composition containing the compound, and a use of the compound and the pharmaceutical composition in preparation of a medicine for enhancing a cGMP signal transduction function or a medicine for treating or preventing sexual dysfunction and diseases with lower urinary tract symptoms.

Heterocyclic Substituted Pyrimidine Compound

The present invention pertains to the field of medical technology, and particularly relates to a heterocyclic substituted pyrimidine compound represented by General Formula (I) and its pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4 and R5 are as defined in the description, the present invention also relates to a preparation method of the compound, a pharmaceutical composition containing the compound, and a use of the compound and the pharmaceutical composition in preparation of a medicine for enhancing a cGMP signal transduction function or a medicine for treating or preventing sexual dysfunction and diseases with lower urinary tract symptoms.